サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1291579

制酸剤市場：世界の産業動向、シェア、規模、成長機会、2023-2028年予測

Antacids Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
出版日: | 発行: IMARC | ページ情報: 英文 143 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.86円
制酸剤市場：世界の産業動向、シェア、規模、成長機会、2023-2028年予測
出版日: 2023年05月29日
発行: IMARC
ページ情報: 英文 143 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の制酸剤市場規模は、2022年に67億米ドルに達しました。今後、IMARC Groupは、2023年から2028年の間に4%の成長率（CAGR）を示し、2028年までに86億米ドルに達すると予測しています。

制酸剤は、胃酸を中和して消化不良や胸焼けを緩和する一般用医薬品です。炭酸水素ナトリウム、アルミニウム、水酸化マグネシウム、カルシウムなどの成分を含み、便利なチュアブル錠、粉末、液体の形態で一般に販売されています。制酸剤は、胃の痛み、消化不良、胃潰瘍、炎症、酸欠、胃もたれの治療に広く使用されています。酸中和剤、促進剤、プロトンポンプ阻害剤は、胃の中の酸を弱める一般的な薬です。十二指腸や食道、食事中に放出される刺激の強い酸から胃の粘膜を保護するのを助けます。これらは自己処方薬であり、胃酸を中和し、ペプシンを阻害することで作用します。

制酸剤の市場動向：

胃食道逆流症（GERD）の有病率の増加は、市場の成長を促進する重要な要因の1つです。制酸剤は、費用対効果が高く、胸焼けに伴う炎症、腫れ、痛み、刺激の緩和をサポートするため、広く使用されています。これに伴い、不規則な食生活、睡眠パターン、座りがちなライフスタイルなどのライフスタイルの変化が、市場の成長にプラスの影響を与えています。さらに、高い効能と作用時間の延長を実現する安全で強い薬であるラフト形成制酸剤の開発など、さまざまな製品イノベーションが市場成長に弾みをつけています。さらに、保存が容易で、正しい服用量を提供し、患者のアドヒアランスを向上させる、さまざまなフレーバーのチュアブルテーブルが広く採用されていることも、市場成長に有利に働いています。その他、酸性の合併症を起こしやすい老年人口の増加、eコマースプラットフォームによる製品の容易な入手、大衆の間での胸焼けの有病率の増加などの要因が、市場に明るい展望をもたらしています。

本レポートで回答した主な質問

  • 世界の制酸剤市場はこれまでどのように推移し、今後数年間はどのように推移するのか？
  • COVID-19は世界の制酸剤市場にどのような影響を与えたか？
  • 主要な地域市場とは？
  • 薬物クラスに基づく市場の内訳は？
  • 製剤タイプに基づく市場内訳は？
  • 流通チャネルに基づく市場の内訳は？
  • 業界のバリューチェーンにおける様々なステージは？
  • 業界における主要な促進要因と課題は何か？
  • 世界の制酸剤市場の構造と主要企業は？
  • 業界における競合の程度は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査目的
  • 利害関係者
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 予測手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要産業動向

第5章 世界の制酸剤市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 薬剤クラス別市場内訳

  • プロトンポンプ阻害剤
    • 市場動向
    • 市場予測
  • H2アンタゴニスト
    • 市場動向
    • 市場予測
  • 酸中和剤
    • 市場動向
    • 市場予測
  • 運動促進剤
    • 市場動向
    • 市場予測

第7章 製剤タイプ別市場内訳

  • 錠剤
    • 市場動向
    • 市場予測
  • 液状
    • 市場動向
    • 市場予測
  • 粉末
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第8章 流通チャネル別市場内訳

  • 病院内薬局
    • 市場動向
    • 市場予測
  • 小売薬局
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第9章 地域別市場内訳

  • 北米
    • 米国
      • 市場動向
      • 市場予測
    • カナダ
      • 市場動向
      • 市場予測
  • アジア太平洋地域
    • 中国
      • 市場動向
      • 市場予測
    • 日本
      • 市場動向
      • 市場予測
    • インド
      • 市場動向
      • 市場予測
    • 韓国
      • 市場動向
      • 市場予測
    • オーストラリア
      • 市場動向
      • 市場予測
    • インドネシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 欧州
    • ドイツ
      • 市場動向
      • 市場予測
    • フランス
      • 市場動向
      • 市場予測
    • 英国
      • 市場動向
      • 市場予測
    • イタリア
      • 市場動向
      • 市場予測
    • スペイン
      • 市場動向
      • 市場予測
    • ロシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • ラテンアメリカ
    • ブラジル
      • 市場動向
      • 市場予測
    • メキシコ
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 中東・アフリカ地域
    • 市場動向
    • 国別市場内訳
    • 市場予測

第10章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の度合い
  • 新規参入業者の脅威
  • 代替品の脅威

第13章 価格分析

第14章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Abbott Laboratories
    • AstraZeneca plc
    • Bayer AG
    • Boehringer Ingelheim International GmbH
    • Dr. Reddy's Laboratories Ltd.
    • GlaxoSmithKline plc
    • Johnson & Johnson
    • Pfizer Inc.
    • Procter & Gamble Company
    • Reckitt Benckiser Group PLC
    • Sanofi S.A.
    • Sun Pharmaceutical Industries Ltd.
    • Takeda Pharmaceutical Company Limited
図表

List of Figures

  • Figure 1: Global: Antacids Market: Major Drivers and Challenges
  • Figure 2: Global: Antacids Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Antacids Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 4: Global: Antacids Market: Breakup by Drug Class (in %), 2022
  • Figure 5: Global: Antacids Market: Breakup by Formulation Type (in %), 2022
  • Figure 6: Global: Antacids Market: Breakup by Distribution Channel (in %), 2022
  • Figure 7: Global: Antacids Market: Breakup by Region (in %), 2022
  • Figure 8: Global: Antacids (Proton Pump Inhibitors) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 9: Global: Antacids (Proton Pump Inhibitors) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 10: Global: Antacids (H2 Antagonist) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 11: Global: Antacids (H2 Antagonist) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 12: Global: Antacids (Acid Neutralizers) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 13: Global: Antacids (Acid Neutralizers) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 14: Global: Antacids (Pro-Motility Agents) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 15: Global: Antacids (Pro-Motility Agents) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 16: Global: Antacids (Tablet) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 17: Global: Antacids (Tablet) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 18: Global: Antacids (Liquid) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 19: Global: Antacids (Liquid) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 20: Global: Antacids (Powder) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 21: Global: Antacids (Powder) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 22: Global: Antacids (Other Formulation Types) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 23: Global: Antacids (Other Formulation Types) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 24: Global: Antacids (Hospital Pharmacies) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 25: Global: Antacids (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 26: Global: Antacids (Retail Pharmacies) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 27: Global: Antacids (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 28: Global: Antacids (Other Distribution Channels) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 29: Global: Antacids (Other Distribution Channels) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 30: North America: Antacids Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 31: North America: Antacids Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 32: United States: Antacids Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 33: United States: Antacids Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 34: Canada: Antacids Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 35: Canada: Antacids Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 36: Asia-Pacific: Antacids Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 37: Asia-Pacific: Antacids Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 38: China: Antacids Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 39: China: Antacids Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 40: Japan: Antacids Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 41: Japan: Antacids Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 42: India: Antacids Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 43: India: Antacids Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 44: South Korea: Antacids Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 45: South Korea: Antacids Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 46: Australia: Antacids Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 47: Australia: Antacids Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 48: Indonesia: Antacids Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 49: Indonesia: Antacids Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 50: Others: Antacids Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 51: Others: Antacids Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 52: Europe: Antacids Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 53: Europe: Antacids Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 54: Germany: Antacids Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 55: Germany: Antacids Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 56: France: Antacids Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 57: France: Antacids Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 58: United Kingdom: Antacids Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 59: United Kingdom: Antacids Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 60: Italy: Antacids Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 61: Italy: Antacids Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 62: Spain: Antacids Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 63: Spain: Antacids Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 64: Russia: Antacids Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 65: Russia: Antacids Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 66: Others: Antacids Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 67: Others: Antacids Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 68: Latin America: Antacids Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 69: Latin America: Antacids Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 70: Brazil: Antacids Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 71: Brazil: Antacids Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 72: Mexico: Antacids Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 73: Mexico: Antacids Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 74: Others: Antacids Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 75: Others: Antacids Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 76: Middle East and Africa: Antacids Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 77: Middle East and Africa: Antacids Market: Breakup by Country (in %), 2022
  • Figure 78: Middle East and Africa: Antacids Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 79: Global: Antacids Industry: SWOT Analysis
  • Figure 80: Global: Antacids Industry: Value Chain Analysis
  • Figure 81: Global: Antacids Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Antacids Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Antacids Market Forecast: Breakup by Drug Class (in Million US$), 2023-2028
  • Table 3: Global: Antacids Market Forecast: Breakup by Formulation Type (in Million US$), 2023-2028
  • Table 4: Global: Antacids Market Forecast: Breakup by Distribution Channel (in Million US$), 2023-2028
  • Table 5: Global: Antacids Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 6: Global: Antacids Market: Competitive Structure
  • Table 7: Global: Antacids Market: Key Players
目次
Product Code: SR112023A5082

The global antacids market size reached US$ 6.7 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 8.6 Billion by 2028, exhibiting a growth rate (CAGR) of 4% during 2023-2028.

Antacids are over-the-counter (OTC) medications that neutralize the acid in the stomach to relieve indigestion and heartburn. They contain ingredients such as sodium bicarbonate, aluminum, magnesium hydroxide, and calcium and are commonly available in convenient chewable tablets, powder, and liquid forms. Antacids are widely used for treating sore stomach, dyspepsia discomfort, stomach ulcers, inflammation, acid indigestion, and stomach upset. Acid neutralizers, promotility agents, and proton pump inhibitors are common drugs that weaken the acid in the stomach. They assist in protecting the stomach lining from the duodenum, esophagus, and harsh acids released while eating. They are self-prescribed medications and act by neutralizing the acid in the stomach and inhibiting pepsin.

Antacids Market Trends:

The increasing prevalence of gastroesophageal reflux diseases (GERD) is one of the key factors driving the growth of the market. Antacids are widely used as they are cost-effective and assist in relieving inflammation, swelling, pain, and irritation associated with heartburn. In line with this, changing lifestyles, such as irregular dietary habits, sleep patterns, and sedentary lifestyles, is positively impacting the market growth. Moreover, various product innovations, such as the development of raft-forming antacids that are safe and strong medications that provide higher efficacy and increased duration of action, are providing an impetus to the market growth. Additionally, the widespread adoption of chewable tables in different flavors that are easy to store, provide the correct amount of dosage, and improve patient adherence is favoring the market growth. Other factors, such as the rising geriatric population that are prone to acidic complications, easy product availability through e-commerce platforms, and the increasing prevalence of heartburn among the masses, are creating a positive outlook for the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global antacids market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on drug class, formulation type and distribution channel.

Breakup by Drug Class:

Proton Pump Inhibitors

H2 Antagonist

Acid Neutralizers

Pro-Motility Agents

Breakup by Formulation Type:

Tablet

Liquid

Powder

Others

Breakup by Distribution Channel:

Hospital Pharmacies

Retail Pharmacies

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, AstraZeneca plc, Bayer AG, Boehringer Ingelheim International GmbH, Dr. Reddy's Laboratories Ltd., GlaxoSmithKline plc, Johnson & Johnson, Pfizer Inc., Procter & Gamble Company, Reckitt Benckiser Group PLC, Sanofi S.A., Sun Pharmaceutical Industries Ltd. and Takeda Pharmaceutical Company Limited.

Key Questions Answered in This Report:

  • How has the global antacids market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global antacids market?
  • What are the key regional markets?
  • What is the breakup of the market based on the drug class?
  • What is the breakup of the market based on the formulation type?
  • What is the breakup of the market based on the distribution channel?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global antacids market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1   Preface

2   Scope and Methodology

  • 2.1  Objectives of the Study
  • 2.2  Stakeholders
  • 2.3  Data Sources
    • 2.3.1  Primary Sources
    • 2.3.2  Secondary Sources
  • 2.4  Market Estimation
    • 2.4.1  Bottom-Up Approach
    • 2.4.2  Top-Down Approach
  • 2.5  Forecasting Methodology

3   Executive Summary

4   Introduction

  • 4.1  Overview
  • 4.2  Key Industry Trends

5   Global Antacids Market

  • 5.1  Market Overview
  • 5.2  Market Performance
  • 5.3  Impact of COVID-19
  • 5.4  Market Forecast

6   Market Breakup by Drug Class

  • 6.1  Proton Pump Inhibitors
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2  H2 Antagonist
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3  Acid Neutralizers
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4  Pro-Motility Agents
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7   Market Breakup by Formulation Type

  • 7.1  Tablet
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2  Liquid
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3  Powder
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4  Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8   Market Breakup by Distribution Channel

  • 8.1  Hospital Pharmacies
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2  Retail Pharmacies
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3  Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9   Market Breakup by Region

  • 9.1  North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2  Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3  Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4  Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5  Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10  SWOT Analysis

  • 10.1  Overview
  • 10.2  Strengths
  • 10.3  Weaknesses
  • 10.4  Opportunities
  • 10.5  Threats

11  Value Chain Analysis

12  Porters Five Forces Analysis

  • 12.1  Overview
  • 12.2  Bargaining Power of Buyers
  • 12.3  Bargaining Power of Suppliers
  • 12.4  Degree of Competition
  • 12.5  Threat of New Entrants
  • 12.6  Threat of Substitutes

13  Price Analysis

14  Competitive Landscape

  • 14.1  Market Structure
  • 14.2  Key Players
  • 14.3  Profiles of Key Players
    • 14.3.1  Abbott Laboratories
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2  AstraZeneca plc
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3  Bayer AG
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4  Boehringer Ingelheim International GmbH
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5  Dr. Reddy's Laboratories Ltd.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6  GlaxoSmithKline plc
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7  Johnson & Johnson
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8  Pfizer Inc.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9  Procter & Gamble Company
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10  Reckitt Benckiser Group PLC
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis
    • 14.3.11  Sanofi S.A.
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
      • 14.3.11.4 SWOT Analysis
    • 14.3.12  Sun Pharmaceutical Industries Ltd.
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 Financials
      • 14.3.12.4 SWOT Analysis
    • 14.3.13  Takeda Pharmaceutical Company Limited
      • 14.3.13.1 Company Overview
      • 14.3.13.2 Product Portfolio
      • 14.3.13.3 Financials
      • 14.3.13.4 SWOT Analysis